Class I - Dangerous
Marketed Without an Approved ANDA/NDA: presence of sibutramine
Marketed Without an Approved ANDA/NDA: presence of sibutramine
Marketed Without an Approved ANDA/NDA: presence of sildenafil.
Marketed Without an Approved ANDA/NDA: presence of sildenafil